160
Participants
Start Date
December 31, 2020
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
TJ107
QW8
TJ107 placebo
QW8
Beijing Tiantan Hospital, Capital Medical University, Beijing
Shenzhen Second People's Hospital, Shenzhen
Harbin Medical University Cancer Hospital, Harbin
Tongji Hospital, Tongji Medical College of HUST, Wuhan
Jiangsu Province Hospital, Nanjing
The Second Affiliated Hospital Of Nanchang University, Nanchang
Liaoning Cancer Hospital & Institute, Shenyang
Shengjing Hospital of China Medical University, Shenyang
General Hospital of Ningxia Medical University, Yinchuan
Tangdu Hospital of The Fourth Military Medical University of Chinese PLA, Xi'an
Peking Union Medical College Hospital, Beijing
Chongqiong Cancer Hospital, Chongqing
Huashan Hospital Affiliated to Fudan University, Shanghai
Tianjin Huanhu Hospital, Tianjin
Tianjin Medical University Cancer Institute & Hospital, Tianjin
Prince of Wales Hospital, Hong Kong
TJ Biopharma Co., Ltd.
INDUSTRY